ES2055783T3 - Peptidos sinteticos, inmunologicamente activos, utiles para la preparacion de vacunas contra la malaria. - Google Patents

Peptidos sinteticos, inmunologicamente activos, utiles para la preparacion de vacunas contra la malaria.

Info

Publication number
ES2055783T3
ES2055783T3 ES89201373T ES89201373T ES2055783T3 ES 2055783 T3 ES2055783 T3 ES 2055783T3 ES 89201373 T ES89201373 T ES 89201373T ES 89201373 T ES89201373 T ES 89201373T ES 2055783 T3 ES2055783 T3 ES 2055783T3
Authority
ES
Spain
Prior art keywords
peptides
synthetic peptides
useful
preparation
immunologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89201373T
Other languages
English (en)
Inventor
Antonio Silvio Verdini
Antonello Pessi
Fabio Bonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eni Tecnologie SpA
Original Assignee
Eniricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche SpA filed Critical Eniricerche SpA
Application granted granted Critical
Publication of ES2055783T3 publication Critical patent/ES2055783T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PEPTIDOS SINTETICOS CONSTITUIDOS POR AL MENOS DOS UNIDADES CONSECUTIVAS REPETIDAS DE SECUENCIA DE ASPARAGINIL - PROLINA. DICHOS PEPTIDOS SON PODEROSOS INMUNOGENOS, CAPACES DE INDUCIR EN ANIMALES DE LABORATORIO LA FORMACION DE UNA ELEVADA CONCENTRACION DE ANTICUERPOS CAPAZ DE REACCIONAR AMBOS CON LOS PEPTIDOS, Y CON EL EPITOPE INMUNODOMINANTE DE LA PROTEINA CISCUNSPOROZOITA DE PLASMODIUM FALCIPARUM. DICHOS PEPTIDOS, QUE PUEDEN SER OBTENIDOS EN FORMA PURA POR SINTESIS QUIMICA SON PARTICULARMENTE UTILES PARA PREPARAR VACUNAS ANTIMALARICAS Y PRUEBAS DE DIAGNOSTICO PARA DETERMINACION DE MALARIA EN HOMBRES.
ES89201373T 1988-06-08 1989-05-30 Peptidos sinteticos, inmunologicamente activos, utiles para la preparacion de vacunas contra la malaria. Expired - Lifetime ES2055783T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8820888A IT8820888A0 (it) 1988-06-08 1988-06-08 Peptidi di sintesi immunologicamente attivi per lapreparazione di vaccini antimalarici.

Publications (1)

Publication Number Publication Date
ES2055783T3 true ES2055783T3 (es) 1994-09-01

Family

ID=11173606

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89201373T Expired - Lifetime ES2055783T3 (es) 1988-06-08 1989-05-30 Peptidos sinteticos, inmunologicamente activos, utiles para la preparacion de vacunas contra la malaria.

Country Status (6)

Country Link
EP (1) EP0345867B1 (es)
JP (1) JPH0236194A (es)
AT (1) ATE87934T1 (es)
DE (1) DE68905860T2 (es)
ES (1) ES2055783T3 (es)
IT (1) IT8820888A0 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
FR2846969A1 (fr) * 2002-11-08 2004-05-14 Salles Jean Pierre Nouveaux vecteurs moleculaires amphiphiles fluorocarbones a usage biomedical et medical

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3211263A1 (de) * 1981-03-31 1983-01-27 Otsuka Pharmaceutical Co. Ltd., Tokyo Human-interferon verwandte peptide, antigene und antikoerper, sowie verfahren zu deren herstellung
ES8800273A1 (es) * 1985-03-28 1987-11-01 Univ New York Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria

Also Published As

Publication number Publication date
DE68905860D1 (de) 1993-05-13
DE68905860T2 (de) 1993-10-28
ATE87934T1 (de) 1993-04-15
IT8820888A0 (it) 1988-06-08
EP0345867A1 (en) 1989-12-13
JPH0236194A (ja) 1990-02-06
EP0345867B1 (en) 1993-04-07

Similar Documents

Publication Publication Date Title
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
IT1237764B (it) Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
EA200100425A1 (ru) Новые способы терапевтической вакцинации
EA200100509A1 (ru) Модифицированные экзосомы и их применение
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
KR910012244A (ko) 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도
NO881151L (no) Syntetisk hiv-1-antigen.
ES2123558T3 (es) Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc.
Arévalo-Herrera et al. Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants
NZ230526A (en) Peptide containing an epitope of circumsporozoite protein of plasmodium falciparum fusion protein, dna sequences
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
ES2055783T3 (es) Peptidos sinteticos, inmunologicamente activos, utiles para la preparacion de vacunas contra la malaria.
AR004567A1 (es) Metodos para detectar la infeccion de t.cruzi, en una muestra biologica, un vector de expresion recombinante, un microorganismo modificado, un kit de diagnostico, una composicion farmaceutica, el uso de la composicion farmaceutica para la preparacion de un medicamento para estimular la produccion de anticuerpos que se liguen a t. cruzi.
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
ES2058240T3 (es) Nuevos peptidos sinteticos inmunologicamente activos utiles para la preparacion de una vacuna antimalarica.
IT1141277B (it) Polipeptide sintetico attivo come antigene,e procedimento per la sua preparazione
ES2058113T3 (es) Metodo de preparacion y uso de antigenos de virus de leucemia felina.
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.
DE3884672D1 (de) Ein synthetisches Nonapeptid zur Verwendung als Adjuvant.
SE8700466L (sv) Vacciner mor melanom
Siddique et al. Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas
Lutz Proctor et al. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 345867

Country of ref document: ES